Source: s3://data.kl3m.ai/documents/govinfo/USCOURTS/USCOURTS-cand-4_07-cv-04972/USCOURTS-cand-4_07-cv-04972-1/pdf.json

Nature of Suit Code: 890
Nature of Suit: Other Statutory Actions
Cause of Action: 28:1331 Fed. Question: Securities Violation

---

1 

2 

3 

4 

5 

6 

7 

8 

9 

10 

11 

12 

13 

14 

15 

16 

17 

18 

19 

20 

21 

22 

23 

24 

25 

26 

27 

28 

STIPULATION AND [PROPOSED] ORDER RE FILING OF FIRST AMENDED COMPLAINT AND 

DEFENDANTS’ RESPONSE THERETO 

CASE NO. CV-07-04972 CW 

MICHAEL L. CHARLSON (Bar No. 122125) 

LAURENCE A. WEISS (Bar No. 164638) 

ALEXANDER M. R. LYON (Bar No. 211274) 

HELLER EHRMAN LLP

275 Middlefield Road 

Menlo Park, California 94025-3506 

Telephone: (650) 324-7000 

Facsimile: (650) 324-0638 

Michael.Charlson@hellerehrman.com 

Laurence.Weiss@hellerehrman.com 

Alexander.Lyon@hellerehrman.com 

Attorneys for Defendants 

THRESHOLD PHARMACEUTICALS, INC., 

HAROLD “BARRY” E. SELICK, and JANET I. SWEARSON 

UNITED STATES DISTRICT COURT 

NORTHERN DISTRICT OF CALIFORNIA 

OAKLAND DIVISION 

JERRY TWINDE, 

Plaintiff, 

vs. 

THRESHOLD PHARMACEUTICALS, 

INC., HAROLD “BARRY” E. SELICK, 

and JANET I. SWEARSON 

Defendants, 

Case No. CV-07-04972 CW 

CLASS ACTION 

STIPULATION AND [PROPOSED] 

ORDER RE FILING OF FIRST 

AMENDED COMPLAINT AND 

DEFENDANTS’ RESPONSE THERETO 

Case 4:07-cv-04972-CW Document 12 Filed 10/25/07 Page 1 of 4
1 

2 

3 

4 

5 

6 

7 

8 

9 

10 

11 

12 

13 

14 

15 

16 

17 

18 

19 

20 

21 

22 

23 

24 

25 

26 

27 

28 

STIPULATION AND [PROPOSED] ORDER RE FILING OF FIRST AMENDED COMPLAINT AND 

DEFENDANTS’ RESPONSE THERETO 

CASE NO. CV-07-04972 CW 

1

WHEREAS on July 5, 2007, plaintiff Jerry Twinde (“Plaintiff”) filed a class action 

complaint against defendants Threshold Pharmaceuticals, Inc., Harold E. Selick, and Janet 

I. Swearson (“Defendants”) in the United States District Court for the Southern District of 

New York entitled Twinde v. Threshold Pharmaceuticals, Inc et al.; 

WHEREAS on July 10, 2007, a second class action complaint was filed against 

Defendants in the United States District Court for the Southern District of New York 

entitled Gilbert v. Threshold Pharmaceuticals, Inc. et al.; 

WHEREAS on September 4, 2007, Michael Hentosh (“Proposed Lead Plaintiff”) 

filed a motion to be appointed to serve as lead plaintiff and to approve selection of 

Plaintiff’s counsel as lead counsel; 

WHEREAS on September 17, 2007, the Court ordered that the Twinde and Gilbert 

actions be transferred to the United States District Court for the Northern District of 

California; 

WHEREAS on September 26, 2007, the Twinde and Gilbert actions were refiled in 

the Northern District of California; 

WHEREAS on October 5, 2007, counsel for Plaintiff and for Proposed Lead Plaintiff 

refiled the motion seeking appointment as lead plaintiff in this Court; 

WHEREAS no other motion to be appointed to serve as lead plaintiff has been filed; 

WHEREAS, if Plaintiff or Proposed Lead Plaintiff is appointed lead plaintiff, or if 

Plaintiff’s counsel is appointed as lead counsel, lead plaintiff will file an amended and 

consolidated complaint; and 

WHEREAS on October 11, 2007, this Court consolidated the Twinde and Gilbert 

actions; 

WHEREAS the parties have not previously requested any extension of time in this 

Court; 

/// 

/// 

/// 

Case 4:07-cv-04972-CW Document 12 Filed 10/25/07 Page 2 of 4
1 

2 

3 

4 

5 

6 

7 

8 

9 

10 

11 

12 

13 

14 

15 

16 

17 

18 

19 

20 

21 

22 

23 

24 

25 

26 

27 

28 

STIPULATION AND [PROPOSED] ORDER RE FILING OF FIRST AMENDED COMPLAINT AND 

DEFENDANTS’ RESPONSE THERETO 

CASE NO. CV-07-04972 CW 

2

IT IS HEREBY STIPULATED and agreed by and among the undersigned counsel 

on behalf of their respective clients that: 

1. Defendants need not respond to the complaint previously filed by Plaintiff’s 

counsel; 

2. If Proposed Lead Plaintiff is appointed lead plaintiff, or if Plaintiff’s counsel 

is appointed as lead counsel, lead plaintiff shall file an amended and consolidated complaint 

within 45 days of the order appointing lead plaintiff; 

3. If an amended and consolidated complaint is filed, Defendants shall answer, 

move to dismiss, or otherwise respond to the amended and consolidated complaint within 

45 days of the filing of the amended and consolidated complaint; 

4. If Defendants move to dismiss the amended and consolidated complaint, lead 

plaintiff shall file his opposition within 45 days of the filing of Defendants’ motion to 

dismiss, and Defendants shall file any reply within 30 days of the filing of plaintiff’s 

opposition. 

/// 

/// 

/// 

/// 

/// 

/// 

/// 

/// 

/// 

/// 

/// 

/// 

/// 

/// 

Case 4:07-cv-04972-CW Document 12 Filed 10/25/07 Page 3 of 4
1 

2 

3 

4 

5 

6 

7 

8 

9 

10 

11 

12 

13 

14 

15 

16 

17 

18 

19 

20 

21 

22 

23 

24 

25 

26 

27 

28 

STIPULATION AND [PROPOSED] ORDER RE FILING OF FIRST AMENDED COMPLAINT AND 

DEFENDANTS’ RESPONSE THERETO 

CASE NO. CV-07-04972 CW 

3

DATED: October 22, 2007 HELLER EHRMAN LLP

275 Middlefield Road 

Menlo Park, California 94025-3506 

Telephone: (650) 324-7000 

Facsimile: (650) 324-0638 

By /s/ Alexander M.R. Lyon 

 Alexander M.R. Lyon 

Attorneys for Defendants 

THRESHOLD PHARMACEUTICALS, INC., 

HAROLD “BARRY” E. SELICK, and JANET I. 

SWEARSON 

DATED: October 22, 2007 COUGHLIN STOIA GELLER RUDMAN & 

ROBBINS LLP 

100 Pine Street, Suite 2600 

San Francisco, CA 94111 

Telephone: (415) 288-4545 

Facsimile: (415) 288-4534 

By /s/ Daniel J. Pfefferbaum 

 Daniel J. Pfefferbaum 

Attorneys for Plaintiff and Proposed Lead Plaintiff 

 

SO ORDERED. 

DATED: _______________ ____________________________________________

HONORABLE CLAUDIA WILKEN 

United States District Court Judge 

10/25/07

Case 4:07-cv-04972-CW Document 12 Filed 10/25/07 Page 4 of 4